Middle East And Africa Refractive Surgery Devices Market
市场规模(十亿美元)
CAGR :
%
USD
38.44 Million
USD
60.59 Million
2021
2029
| 2022 –2029 | |
| USD 38.44 Million | |
| USD 60.59 Million | |
|
|
|
中东和非洲屈光手术设备市场,按产品类型(激光器、有晶体眼人工晶状体 (IOL)、像差仪/波前像差仪、手术器械及配件、屈光手术套件、瞳孔直径仪、角膜上皮刀、微型角膜刀、热角膜成形术、角膜缘松弛切口套件等)、手术类型(LASIK(激光原位角膜磨镶术、光屈光性角膜切削术 (PRK)、有晶体眼人工晶状体 (IOL)、散光角膜切开术 (AK)、自动板层角膜移植术 (ALK)、角膜内环 (INTACS)、激光热角膜移植术 (LTK)、传导性角膜移植术 (CK)、放射状角膜切开术 (RK) 等)、应用(近视 (Myopia)、远视 (Hypitality)、散光和老花眼)、最终用户(医院、专科诊所、门诊手术中心等)、分销渠道(直接招标、第三方分销商等)行业趋势及预测至 2029 年。
市场定义和见解
屈光手术设备用于改善或矫正屈光不正,例如近视、远视、老花眼或散光。这些设备包括准分子激光器、YAG激光器、微型角膜刀和飞秒激光器。屈光手术大大减少了对眼镜或隐形眼镜的依赖。市场上有各种屈光设备用于治疗视力缺陷。


屈光不正是由于角膜或眼球形状不合适而引起的。屈光手术包括使用各种屈光手术设备(如先进的激光、LASIK 治疗、光屈光性角膜切除术)和各种晶状体(如晶状体眼人工晶状体和散光人工晶状体)重塑眼球或角膜。
屈光手术设备市场预计将在 2022 年至 2029 年的预测期内实现市场增长。Data Bridge Market Research 分析称,在 2022 年至 2029 年的预测期内,该市场以 6.1% 的复合年增长率增长,预计将从 2021 年的 3844 万美元达到 2029 年的 6059 万美元。
|
报告指标 |
细节 |
|
预测期 |
2022 至 2029 年 |
|
基准年 |
2021 |
|
历史岁月 |
2020(可定制至 2019 - 2014) |
|
定量单位 |
收入(百万美元) |
|
涵盖的领域 |
按产品类型(激光器、有晶体眼人工晶状体 (IOL)、像差仪/波前像差仪、手术器械及配件、屈光手术套件、瞳孔直径测量仪、角膜上皮刀、微型角膜刀、热角膜成形术、角膜缘松弛切开套件等)、手术类型(LASIK(激光原位角膜磨镶术、光屈光性角膜切削术 (PRK)、有晶体眼人工晶状体 (IOL)、散光角膜切开术 (AK)、自动板层角膜移植术 (ALK)、角膜内环 (INTACS)、激光热角膜移植术 (LTK)、传导性角膜移植术 (CK)、放射状角膜切开术 (RK) 等)、应用(近视、远视、散光和老花眼)、最终用户(医院、专科诊所、门诊手术中心等)、分销渠道(直接招标、第三方分销商等) |
|
覆盖国家 |
南非、沙特阿拉伯、阿联酋、埃及、以色列、科威特、中东和非洲其他地区 |
|
涵盖的市场参与者 |
Tracey Technologies、Bausch + Lomb Incorporated、BD、STAAR SURGICAL、SCHWIND eye-tech-solutions、Hoya Surgical Optics、Johnson & Johnson Services, Inc.、Ophtec BV、Glaukos Corporation、Amplitude Laser、Reichert, Inc.、NIDEK CO., LTD.、Ziemer Ophthalmic Systems、ROWIAK GmbH、Moria、LENSAR, Inc.、Topcon Canada Inc.(Topcon Corporation 的子公司)、Aaren Scientific Inc.、Rayner Intraocular Lenses Limited.、iVIS Technologies、Alcon 等 |
屈光手术设备市场的市场动态包括
驱动程序
- 技术进步的提高
过去几年,医疗保健领域的技术发展速度大幅提升。屈光手术设备技术的进步有助于在疾病管理过程中实现无痛、简单的治疗。此外,各种屈光手术设备的创新和升级有助于准确、快速地诊断疾病。屈光手术设备的创新还为疾病治疗过程中基于技术的治疗工具提供了成本效益。
例如,
- 根据 Contoura Vision India 的说法,Contoura 视力手术是摘除眼镜的最新先进眼科手术。它是眼科手术中最安全的技术进步之一,不仅可以矫正眼镜的度数,还可以治疗角膜不规则
- 据眼科和激光中心组织称,2017 年 5 月,Visumax 飞秒激光技术是最先进的屈光手术治疗方法之一。它能够修复眼睛的视力缺陷
各种屈光手术设备的技术进步,例如激光可变点扫描技术的进步,预计将推动屈光手术设备市场的发展。因此,屈光手术设备的不断创新和技术进步预计将在预测期内推动市场增长。
- 医疗支出增加
在过去十年中,为了提供更好的患者医疗服务,医疗支出大幅增加。美国是最大的医疗市场,过去几年其医疗总支出大幅增加。支出增长的根本目的是提供合适、负担得起且高质量的屈光手术设备。为了促进人口健康并解决发达国家和发展中国家的医疗紧急情况,相关政府机构和医疗组织正在采取主动行动,加快医疗支出。
例如,
- 据美国卫生事务组织称,2020 年美国医疗保健支出增长 9.7%,达到 4.1 万亿美元,增速远高于 2019 年
- 据英国政府称,2020 年,政府已拨款近 2.5 亿英镑(约合 3 亿美元),用于利用最新技术实现 NHS(国家医疗服务体系)诊断护理的数字化和改进。这笔资金专门用于 NHS 诊断服务的技术改进,以便尽早发现并开始治疗健康状况
- 印度政府已推出国家免费诊断服务计划,作为国家健康使命的一部分。这项计划对于在同一屋檐下免费提供全面优质的医疗服务至关重要。在印度政府的这项计划下,多个州尝试了多种模式,以确保公共卫生机构能够提供诊断服务
医疗支出的增长也有利于进一步的经济增长以及医疗行业的增长。它显著影响了新诊断测试和新手术工具的开发。因此,巨大的医疗支出是市场增长的有利因素。
机会
- LASIK 手术的成就
LASIK 的成功率或 LASIK 效果众所周知,有数千项临床研究关注视力和患者满意度。最近的研究报告称,99% 的患者视力超过 20/40,超过 90% 的患者视力达到 20/20 或更高。此外,LASIK 的患者满意率达到前所未有的 96%,是所有选择性手术中最高的。
例如,
- 《白内障与屈光手术杂志》 2016 年的一项研究发现,LASIK 患者满意率为 96%
2018 年文章《LASIK:了解其好处和风险》
- Eric Donnenfeld 医学博士曾任美国白内障和屈光手术协会主席,在其 28 年的职业生涯中完成了约 85,000 例手术
- 据 Market Scope 称,自 1999 年 FDA 首次批准 LASIK 手术以来,约有 1000 万美国人接受了该手术。每年约有 70 万例 LASIK 手术,但与 2000 年 140 万例的峰值相比有所下降
从今以后,全球范围内成功实施 LASIK 手术的数量不断增加与产品开发、产品注册和产品发布密切相关。因此,预计这将在未来几年推动屈光手术设备市场的发展。
- 市场参与者的战略举措
全球范围内屈光不正负担的增加为屈光手术设备市场带来了更多需求。主要目的是通过开发创新产品和手术类型来改善健康管理,以方便使用,提供优质护理。屈光手术设备市场的主要参与者已经采取了战略举措,包括产品发布、收购等,预计将引领屈光手术设备市场并创造更多机会。
例如,
- 2021 年 6 月,Glaukos Corporation 获得了澳大利亚治疗用品管理局 (TGA) 的 PRESERFLO MicroShunt 监管批准。PRESERFLO MicroShunt 旨在降低原发性开角型青光眼患者的眼压 (IOP),这些患者的眼压将无法控制,并且是最大耐受的药物治疗和/或青光眼进展需要手术治疗
- 2021 年 6 月:博士伦公司与信息技术服务业公司 Lochan 签署了一项协议。这些公司旨在开发博士伦公司的下一代 eyeTELLIGENCE 临床决策支持软件。通过利用 eyeTELLIGENCE 现有的基于云的基础设施,该软件将得以开发,使外科医生能够毫不费力地结合白内障、视网膜和屈光手术程序的所有因素,以提高他们的整体实践效率
- 2021 年 3 月,NIDEK 推出了适用于 Windows 的 RT-6100 CB、RT-6100 智能验光仪的可选控制软件以及 TS-610 台式验光系统。该软件可满足患者和操作员的不同需求。此外,该软件还可以进行验光,满足社交距离要求
屈光手术设备市场的主要公司推出的众多战略产品和收购为全球公司打开了机遇。这些战略使公司能够加强其在市场上的影响力。因此,据预测,战略举措是市场参与者加速其市场收入增长的黄金机会。
挑战/限制
- 人们对该手术的好处缺乏认识和信任
在许多国家,普通民众并不了解屈光手术,也不知道它对近视散光、老花眼等屈光不正的各种好处。人们害怕手术会导致一些严重的副作用,这预计将给市场带来巨大挑战。
例如,
- 根据美国国立卫生研究院 (NIH) 2021 年的研究,人们拒绝接受手术,因为他们担心手术并发症,并且缺乏有关手术的信息。此外,研究还显示,82.5% 的参与者由于缺乏意识而不知道屈光手术可以提高他们的视力
- 根据《国际医学杂志在发展中国家》2019年的一项研究,指出:
- 32.2% 的受访者认为屈光手术很危险,9.5% 的受访者认为手术会导致严重的并发症
- 此外,印度的研究还显示,64% 的参与者不知道屈光手术能够改善他们的视力
人们对屈光手术益处的认识不足以及对手术并发症的恐惧预计将对市场增长造成巨大挑战。
- 缺乏眼科治疗医疗设施
中低收入国家的贫困人口比富裕人口更容易患失明和眼科疾病。发达国家的进步和战略计划在低收入国家并不同样适用。许多低收入国家通常依靠社区卫生工作者、医师助理和白内障外科医生进行最初的初级眼科护理。低收入国家 (LIC) 的眼科治疗非常具有挑战性,因为它具有热带气候、脆弱的电网、糟糕的道路和水利基础设施、有限的诊断能力以及有限的治疗选择等复杂性。
例如,
- 根据《低收入国家眼科的创新诊断工具》一文,2020 年的报告指出,高收入国家失明和眼部疾病的患病率为每 1,000 人 0.3 人,但低收入国家估计为每 1,000 人 1.5 人。这表明低收入国家对眼科护理的需求尚未得到满足
低收入国家的另一个主要问题是人们对眼部疼痛和其他疾病缺乏认识。许多研究报告指出,低收入国家对眼部保健的需求很高,其未满足的需求仍在引起许多医疗保健组织的关注。
例如,
- 2014 年《英国眼科学杂志》报道称,由于缺乏针对中低收入国家的举措,政府发起的 2020 愿景计划仍远未实现
因此,中低收入国家眼科治疗医疗设施差被认为是屈光手术设备市场增长的最大挑战。
COVID-19 对屈光手术设备市场的影响
COVID-19 已经影响了市场。疫情期间的封锁和隔离限制了群众的流动。因此,手术日期和时间被推迟。因此,疫情对这个市场产生了负面影响
近期发展
- 2021 年 7 月,强生视力推出了 VERITAS 视力系统,这是新一代超声乳化 (phaco) 系统。该系统的开发旨在照顾三个重要领域:外科医生效率、患者安全和舒适度。这增加了公司的产品组合
屈光手术设备市场范围
屈光手术设备市场分为产品类型、手术类型、应用、最终用户和分销渠道。这些细分市场之间的增长将帮助您分析行业中增长微弱的细分市场,并为用户提供有价值的市场概览和市场洞察,以便做出战略决策,确定核心市场应用。
产品类型
- 激光
- 有晶状体眼人工晶状体 (IOL)
- 像差仪/波前像差仪
- 手术器械及配件
- 屈光手术套件
- 瞳孔直径测量仪
- 表皮角膜刀
- 微型角膜刀
- 热角膜成形术
- 角膜缘松弛切开套件
- 其他的
根据产品类型,屈光手术设备市场细分为激光器、有晶状体眼人工晶状体 (IOL)、像差仪/波前像差仪、手术器械及配件、屈光手术套件、瞳孔直径测量仪、表皮角膜刀、微型角膜刀、热角膜成形术、角膜缘松解切口套件等。
手术类型
- Lasik(激光原位角膜磨镶术)
- 屈光性角膜切削术 (PRK)
- 有晶状体眼人工晶状体 (IOL)
- 散光角膜切开术(AK)
- 自动板层角膜移植术 (ALK)
- 角膜内环 (INTACS)
- 激光热角膜移植术 (LTK)
- 传导性角膜移植术 (CK)
- 放射状角膜切开术 (RK)
- 其他的
根据手术类型,屈光手术设备市场细分为 LASIK(激光原位角膜磨镶术)、屈光性角膜切削术(PRK)、有晶状体眼人工晶状体(IOL)、散光角膜切开术(AK)、自动板层角膜移植术(ALK)、角膜内环(INTACS)、激光热角膜移植术(LTK)、传导性角膜移植术(CK)、放射状角膜切开术(RK)等。
应用
- 近视
- 远视
- 散光
- 老花眼
根据应用,屈光手术设备市场分为近视、远视、散光和老花眼。
最终用户
- 医院
- 专科诊所
- 门诊手术中心
- 其他的
根据最终用户,屈光手术设备市场分为医院、专科诊所、门诊手术中心和其他。
分销渠道
- 直接招标
- 第三方分销商
- 其他的

根据分销渠道,屈光手术设备市场分为直接招标、第三方分销商和其他。
屈光手术设备市场区域分析/见解
The refractive surgery devices market is analysed and market size insights and trends are provided by country, product type, surgery type, application, end user, and distribution channel as referenced above.
The countries covered in the refractive surgery devices market report are the Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Kuwait, Rest of Middle East and Africa.
South Africa dominates the refractive surgery devices market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period due to increase in the number of refractive surgeries in the region and technological advancements.
The country section of the report also provides individual market impacting factors and changes in regulations in the market that impact the current and future trends of the market. Data points, such as new and replacement sales, country demographics, disease epidemiology, and import-export tariffs, are some of the major pointers used to forecast the market scenario for individual countries. In addition, the presence and availability of brands and their challenges faced due to high competition from local and domestic brands, and impact of sales channels are considered while providing forecast analysis of the country data.
Competitive Landscape and Refractive Surgery Devices Market Share Analysis
The refractive surgery devices market competitive landscape provides details by the competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies' focus on refractive surgery devices market.
Some of the major companies dealing in the refractive surgery devices market are Tracey Technologies, Bausch + Lomb Incorporated, BD, STAAR SURGICAL, SCHWIND eye-tech-solutions, Hoya Surgical Optics, Johnson & Johnson Services, Inc., Ophtec BV, Glaukos Corporation, Amplitude Laser, Reichert, Inc., NIDEK CO., LTD., Ziemer Ophthalmic Systems, ROWIAK GmbH, Moria, LENSAR, Inc., Topcon Canada Inc. (A subsidiary of Topcon Corporation), Aaren Scientific Inc., Rayner Intraocular Lenses Limited., iVIS Technologies, Alcon, among others.
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analysed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, vs. Regional and Vendor Share Analysis. Please request analyst call in case of further inquiry.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF MIDDLE EAST & AFRICA REFRACTIVE SURGERY DEVICES MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL'S MODEL
4.2 PORTER'S FIVE FORCES MODEL
4.3 MIDDLE EAST & AFRICA REFRACTIVE SURGERY DEVICES MARKET: REGULATIONS
4.3.1 REGULATION IN THE U.S.
4.3.2 REGULATIONS IN EUROPE
4.3.3 REGULATIONS IN SINGAPORE
4.3.4 REGULATIONS IN AUSTRALIA
5 MARKET OVERVIEW
5.1 DRIVERS
5.1.1 INCREASING TECHNOLOGICAL ADVANCEMENT
5.1.2 RISE IN HEALTHCARE EXPENDITURE
5.1.3 INCREASE IN POPULATION WITH MACULAR DEGENERATION
5.1.4 RISE IN ADOPTION OF MINIMALLY INVASIVE SURGERIES
5.2 RESTRAINTS
5.2.1 STRINGENT RULES AND REGULATIONS
5.2.2 HIGH COST ASSOCIATED WITH REFRACTIVE SURGERY DEVICES
5.2.3 SIDE EFFECTS OF SURGERY
5.3 OPPORTUNITIES
5.3.1 ACHIEVEMENTS IN LASIK SURGERIES
5.3.2 STRATEGIC INITIATIVES BY MARKET PLAYERS
5.3.3 INCREASING GERIATRIC POPULATION
5.3.4 EXCESSIVE USAGE OF DIGITAL DEVICES
5.4 CHALLENGES
5.4.1 DEARTH OF SKILLED PROFESSIONALS
5.4.2 LACK OF HEALTHCARE FACILITIES FOR EYE TREATMENT
6 COVID-19 IMPACT ON MIDDLE EAST & AFRICA REFRACTIVE SURGERY DEVICES MARKET
6.1 IMPACT ON PRICE
6.2 IMPACT ON DEMAND
6.3 IMPACT ON SUPPLY
6.4 STRATEGIC DECISIONS BY MANUFACTURERS
6.5 CONCLUSION
7 MIDDLE EAST & AFRICA REFRACTIVE SURGERY DEVICES MARKET, BY PRODUCT TYPE
7.1 OVERVIEW
7.2 LASER
7.2.1 EXCIMER LASERS
7.2.2 FEMTOSECOND LASER/ULTRASHORT PULSE LASER
7.2.3 OTHERS
7.3 PHAKIC INTRAOCULAR LENS (IOL)
7.4 ABERROMETERS / WAVEFRONT ABERROMETRY
7.5 SURGICAL INSTRUMENTS & ACCESSORIES
7.6 REFRACTIVE SURGERY KITS
7.7 PUPILLARY DIAMETER METERS
7.8 EPIKERATOMES
7.9 MICROKERATOMES
7.1 THERMOKERATOPLASTY
7.11 LIMBAL RELAXING INCISION KITS
7.12 OTHERS
8 MIDDLE EAST & AFRICA REFRACTIVE SURGERY DEVICES DISEASE MARKET, BY SURGERY TYPE
8.1 OVERVIEW
8.2 LASIK (LASER IN-SITU KERATOMILEUSIS)
8.3 PHOTOREFRACTIVE KERATECTOMY (PRK)
8.4 PHAKIC INTRAOCULAR LENSES (IOL)
8.5 ASTIGMATIC KERATOTOMY (AK)
8.6 AUTOMATED LAMELLAR KERATOPLASTY (ALK)
8.7 INTRACORNEAL RING (INTACS)
8.8 LASER THERMAL KERATOPLASTY (LTK)
8.9 CONDUCTIVE KERATOPLASTY (CK)
8.1 RADIAL KERATOTOMY (RK)
8.11 OTHERS
9 MIDDLE EAST & AFRICA REFRACTIVE SURGERY DEVICES DISEASE MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 NEARSIGHTEDNESS (MYOPIA)
9.3 FARSIGHTEDNESS (HYPEROPIA)
9.4 PRESBYOPIA
9.5 ASTIGMATISM
10 MIDDLE EAST & AFRICA REFRACTIVE SURGERY DEVICES DISEASE MARKET, BY END USER
10.1 OVERVIEW
10.2 HOSPITAL
10.3 SPECIALTY CLINICS
10.4 AMBULATORY SURGICAL CENTERS
10.5 OTHERS
11 MIDDLE EAST & AFRICA REFRACTIVE SURGERY DEVICES DISEASE MARKET, BY DISTRIBUTION CHANNEL
11.1 OVERVIEW
11.2 DIRECT TENDER
11.3 THIRD PARTY DISTRIBUTORS
11.4 OTHERS
12 MIDDLE EAST & AFRICA REFRACTIVE SURGERY DEVICES MARKET, BY REGION
12.1 MIDDLE EAST AND AFRICA
12.1.1 SOUTH AFRICA
12.1.2 SAUDI ARABIA
12.1.3 U.A.E.
12.1.4 EGYPT
12.1.5 ISRAEL
12.1.6 KUWAIT
12.1.7 REST OF MIDDLE EAST AND AFRICA
13 MIDDLE EAST & AFRICA REFRACTIVE SURGERY DEVICES MARKET: COMPANY LANDSCAPE
13.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA
14 SWOT ANALYSIS
15 COMPANY PROFILE
15.1 JOHNSON AND JOHNSON SERVICES, INC.
15.1.1 COMPANY SNAPSHOT
15.1.2 REVENUE ANALYSIS
15.1.3 COMPANY SHARE ANALYSIS
15.1.4 PRODUCT PORTFOLIO
15.1.5 RECENT DEVELOPMENT
15.1.5.1 PRODUCT LAUNCH
15.2 ALCON INC.
15.2.1 COMPANY SNAPSHOT
15.2.2 REVENUE ANALYSIS
15.2.3 COMPANY SHARE ANALYSIS
15.2.4 PRODUCT PORTFOLIO
15.2.5 RECENT DEVELOPMENTS
15.2.5.1 ACQUISITION
15.2.5.2 PRODUCT LAUNCH
15.3 STAAR SURGICAL
15.3.1 COMPANY SNAPSHOT
15.3.2 REVENUE ANALYSIS
15.3.3 COMPANY SHARE ANALYSIS
15.3.4 PRODUCT PORTFOLIO
15.3.5 RECENT DEVELOPMENTS
15.4 BAUSCH + LOMB INCORPORATED
15.4.1 COMPANY SNAPSHOT
15.4.2 REVENUE ANALYSIS
15.4.3 COMPANY SHARE ANALYSIS
15.4.4 PRODUCT PORTFOLIO
15.4.5 RECENT DEVELOPMENT
15.4.5.1 ACQUISITION
15.4.5.2 CE APPROVAL
15.5 TOPCON CANADA INC., (A SUBSIDIARY OF TOPCON CORPORATION)
15.5.1 COMPANY SNAPSHOT
15.5.2 REVENUE ANALYSIS
15.5.3 COMPANY SHARE ANALYSIS
15.5.4 PRODUCT PORTFOLIO
15.5.5 RECENT DEVELOPMENTS
15.5.5.1 PARTNERSHIP
15.5.5.2 ACQUISITION
15.6 AAREN SCIENTIFIC INC.
15.6.1 COMPANY SNAPSHOT
15.6.2 PRODUCT PORTFOLIO
15.6.3 RECENT DEVELOPMENT
15.7 AMPLITUDE LASER
15.7.1 COMPANY SNAPSHOT
15.7.2 PRODUCT PORTFOLIO
15.7.3 RECENT DEVELOPMENTS
15.7.3.1 PARTNERSHIP
15.8 BD
15.8.1 COMPANY SNAPSHOT
15.8.2 REVENUE ANALYSIS
15.8.3 PRODUCT PORTFOLIO
15.8.4 RECENT DEVELOPMENTS
15.8.4.1 CONFERENCE
15.8.4.2 PRODUCT LAUNCH
15.9 GLAUKOS CORPORATION
15.9.1 COMPANY SNAPSHOT
15.9.2 REVENUE ANALYSIS
15.9.3 PRODUCT PORTFOLIO
15.9.4 RECENT DEVELOPMENTS
15.9.4.1 PRODUCT LAUNCH
15.9.4.2 ACQUISITION
15.1 HOYA SURGICAL OPTICS
15.10.1 COMPANY SNAPSHOT
15.10.2 PRODUCT PORTFOLIO
15.10.3 RECENT DEVELOPMENT
15.10.3.1 CONFERENCE
15.11 IVIS TECHNOLOGIES
15.11.1 COMPANY SNAPSHOT
15.11.2 PRODUCT PORTFOLIO
15.11.3 RECENT DEVELOPMENTS
15.12 LENSAR INC. (A SUBSDIARY OF PDL BIOPHARMA, INC.)
15.12.1 COMPANY SNAPSHOT
15.12.2 PRODUCT PORTFOLIO
15.12.3 RECENT DEVELOPMENTS
15.13 MORIA
15.13.1 COMPANY SNAPSHOT
15.13.2 PRODUCT PORTFOLIO
15.13.3 RECENT DEVELOPMENT
15.14 NIDEK CO., LTD
15.14.1 COMPANY SNAPSHOT
15.14.2 PRODUCT PORTFOLIO
15.14.3 RECENT DEVELOPMENT
15.14.3.1 WEBSITE LAUNCH
15.15 OPHTEC BV
15.15.1 COMPANY SNAPSHOT
15.15.2 PRODUCT PORTFOLIO
15.15.3 RECENT DEVELOPMENT
15.15.3.1 PRODUCT LAUNCH
15.16 RAYNER INTRAOCULAR LENSES LIMITED
15.16.1 COMPANY SNAPSHOT
15.16.2 PRODUCT PORTFOLIO
15.16.3 RECENT DEVELOPMENTS
15.16.3.1 NEW DISTRIBUTION UNIT
15.16.3.2 ACQUISITION
15.16.3.3 ACQUISITION
15.17 REICHERT, INC.
15.17.1 COMPANY SNAPSHOT
15.17.2 PRODUCT PORTFOLIO
15.17.3 RECENT DEVELOPMENT
15.17.3.1 CONFERENCE
15.18 ROWIAK GMBH
15.18.1 COMPANY SNAPSHOT
15.18.2 PRODUCT PORTFOLIO
15.18.3 RECENT DEVELOPMENT
15.18.3.1 R&D FACILITY
15.19 SCHWIND EYE-TECH-SOLUTIONS
15.19.1 COMPANY SNAPSHOT
15.19.2 PRODUCT PORTFOLIO
15.19.3 RECENT DEVELOPMENTS
15.2 TRACEY TECHNOLOGIES
15.20.1 COMPANY SNAPSHOT
15.20.2 PRODUCT PORTFOLIO
15.20.3 RECENT DEVELOPMENT
15.20.3.1 R&D FACILITY
15.21 ZIEMER OPHTHALMIC SYSTEMS
15.21.1 COMPANY SNAPSHOT
15.21.2 PRODUCT PORTFOLIO
15.21.3 RECENT DEVELOPMENT
15.21.3.1 AGREEMENT
16 QUESTIONNAIRE
17 RELATED REPORTS
表格列表
TABLE 1 MIDDLE EAST & AFRICA REFRACTIVE SURGERY DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 2 MIDDLE EAST & AFRICA LASER IN REFRACTIVE SURGERY DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 3 MIDDLE EAST & AFRICA LASER IN REFRACTIVE SURGERY DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 4 MIDDLE EAST & AFRICA PHAKIC INTRAOCULAR LENS (IOL) IN REFRACTIVE SURGERY DEIVCES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 5 MIDDLE EAST & AFRICA ABBEROMETERS/WAFEFRONT ABERROMETRY IN REFRACTIVE SURGERY DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 6 MIDDLE EAST & AFRICA SURGICAL INSTRUMENT & ACCESSORIES IN REFRACTIVE SURGERY DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 7 MIDDLE EAST & AFRICA REFRACTIVE SURGERY KITS IN REFRACTIVE SURGERY DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 8 MIDDLE EAST & AFRICA PUPILLARY DIAMETER METERS IN REFRACTIVE SURGERY DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 9 MIDDLE EAST & AFRICA EPIKERATOMES IN REFRACTIVE SURGERY DEIVCES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 10 MIDDLE EAST & AFRICA MICROKERATOMES IN REFRACTIVE SURGERY DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 11 MIDDLE EAST & AFRICA THERMOKERATOPLASTY IN REFRACTIVE SURGERY DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 12 MIDDLE EAST & AFRICA LIMBAL RELAXING INCISION KITS IN REFRACTIVE SURGERY DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 13 MIDDLE EAST & AFRICA OTHERS IN REFRACTIVE SURGERY DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 14 MIDDLE EAST & AFRICA REFRACTIVE SURGERY DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)
TABLE 15 MIDDLE EAST & AFRICA LASIK (LASER IN-SITU KERATOMILEUSIS) IN REFRACTIVE SURGERY DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 16 MIDDLE EAST & AFRICA PHOTOREFRACTIVE KERATECTOMY (PRK) IN REFRACTIVE SURGERY DEIVCES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 17 MIDDLE EAST & AFRICA PHAKIC INTRAOCULAR LENSES (IOL) IN REFRACTIVE SURGERY DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 18 MIDDLE EAST & AFRICA ASTIGMATIC KERATOTOMY (AK) IN REFRACTIVE SURGERY DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 19 MIDDLE EAST & AFRICA AUTOMATED LAMELLAR KERATOPLASTY (ALK) IN REFRACTIVE SURGERY DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 20 MIDDLE EAST & AFRICA INTRACORNEAL RING (INTACS) IN REFRACTIVE SURGERY DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 21 MIDDLE EAST & AFRICA LASER THERMAL KERATOPLASTY (LTK) IN REFRACTIVE SURGERY DEIVCES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 22 MIDDLE EAST & AFRICA CONDUCTIVE KERATOPLASTY (CK) IN REFRACTIVE SURGERY DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 23 MIDDLE EAST & AFRICA RADIAL KERATOTOMY (RK) IN REFRACTIVE SURGERY DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 24 MIDDLE EAST & AFRICA OTHERS IN REFRACTIVE SURGERY DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 25 MIDDLE EAST & AFRICA REFRACTIVE SURGERY DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 26 MIDDLE EAST & AFRICA NEARSIGHTEDNESS (MYOPIA) IN REFRACTIVE SURGERY DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 27 MIDDLE EAST & AFRICA FARSIGHTEDNESS (HYPEROPIA) IN REFRACTIVE SURGERY DEIVCES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 28 MIDDLE EAST & AFRICA PRESBYOPIA IN REFRACTIVE SURGERY DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 29 MIDDLE EAST & AFRICA ASTIGMATISM IN REFRACTIVE SURGERY DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 30 MIDDLE EAST & AFRICA REFRACTIVE SURGERY DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 31 MIDDLE EAST & AFRICA HOSPITALS IN REFRACTIVE SURGERY DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 32 MIDDLE EAST & AFRICA SPECIALTY CLINICS IN REFRACTIVE SURGERY DEIVCES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 33 MIDDLE EAST & AFRICA AMBULATORY SURGICAL CENTERS IN REFRACTIVE SURGERY DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 34 MIDDLE EAST & AFRICA OTHERS IN REFRACTIVE SURGERY DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 35 MIDDLE EAST & AFRICA REFRACTIVE SURGERY DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 36 MIDDLE EAST & AFRICA DIRECT TENDER IN REFRACTIVE SURGERY DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 37 MIDDLE EAST & AFRICA THIRD PARTY DISTRIBUTORS IN REFRACTIVE SURGERY DEIVCES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 38 MIDDLE EAST & AFRICA OTHERS IN REFRACTIVE SURGERY DEVICES MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 39 MIDDLE EAST AND AFRICA REFRACTIVE SURGERY DEVICES MARKET, BY COUNTRY, 2020-2029 (USD MILLION)
TABLE 40 MIDDLE EAST AND AFRICA REFRACTIVE SURGERY DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 41 MIDDLE EAST AND AFRICA LASER IN REFRACTIVE SURGERY DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 42 MIDDLE EAST AND AFRICA REFRACTIVE SURGERY DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)
TABLE 43 MIDDLE EAST AND AFRICA REFRACTIVE SURGERY DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 44 MIDDLE EAST AND AFRICA REFRACTIVE SURGERY DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 45 MIDDLE EAST AND AFRICA REFRACTIVE SURGERY DEVICES MARKET, DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 46 SOUTH AFRICA REFRACTIVE SURGERY DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 47 SOUTH AFRICA LASER IN REFRACTIVE SURGERY DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 48 SOUTH AFRICA REFRACTIVE SURGERY DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)
TABLE 49 SOUTH AFRICA REFRACTIVE SURGERY DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 50 SOUTH AFRICA REFRACTIVE SURGERY DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 51 SOUTH AFRICA REFRACTIVE SURGERY DEVICES MARKET, DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 52 SAUDI ARABIA REFRACTIVE SURGERY DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 53 SAUDI ARABIA LASER IN REFRACTIVE SURGERY DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 54 SAUDI ARABIA REFRACTIVE SURGERY DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)
TABLE 55 SAUDI ARABIA REFRACTIVE SURGERY DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 56 SAUDI ARABIA REFRACTIVE SURGERY DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 57 SAUDI ARABIA REFRACTIVE SURGERY DEVICES MARKET, DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 58 U.A.E. REFRACTIVE SURGERY DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 59 U.A.E. LASER IN REFRACTIVE SURGERY DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 60 U.A.E. REFRACTIVE SURGERY DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)
TABLE 61 U.A.E. REFRACTIVE SURGERY DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 62 U.A.E. REFRACTIVE SURGERY DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 63 U.A.E. REFRACTIVE SURGERY DEVICES MARKET, DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 64 EGYPT REFRACTIVE SURGERY DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 65 EGYPT LASER IN REFRACTIVE SURGERY DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 66 EGYPT REFRACTIVE SURGERY DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)
TABLE 67 EGYPT REFRACTIVE SURGERY DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 68 EGYPT REFRACTIVE SURGERY DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 69 EGYPT REFRACTIVE SURGERY DEVICES MARKET, DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 70 ISRAEL REFRACTIVE SURGERY DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 71 ISRAEL LASER IN REFRACTIVE SURGERY DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 72 ISRAEL REFRACTIVE SURGERY DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)
TABLE 73 ISRAEL REFRACTIVE SURGERY DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 74 ISRAEL REFRACTIVE SURGERY DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 75 ISRAEL REFRACTIVE SURGERY DEVICES MARKET, DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 76 KUWAIT REFRACTIVE SURGERY DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 77 KUWAIT LASER IN REFRACTIVE SURGERY DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 78 KUWAIT REFRACTIVE SURGERY DEVICES MARKET, BY SURGERY TYPE, 2020-2029 (USD MILLION)
TABLE 79 KUWAIT REFRACTIVE SURGERY DEVICES MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 80 KUWAIT REFRACTIVE SURGERY DEVICES MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 81 KUWAIT REFRACTIVE SURGERY DEVICES MARKET, DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 82 REST OF MIDDLE EAST AND AFRICA REFRACTIVE SURGERY DEVICES MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
图片列表
FIGURE 1 MIDDLE EAST & AFRICA REFRACTIVE SURGERY DEVICES MARKET: SEGMENTATION
FIGURE 2 MIDDLE EAST & AFRICA REFRACTIVE SURGERY DEVICES MARKET: DATA TRIANGULATION
FIGURE 3 MIDDLE EAST & AFRICA REFRACTIVE SURGERY DEVICES MARKET: DROC ANALYSIS
FIGURE 4 MIDDLE EAST & AFRICA REFRACTIVE SURGERY DEVICES MARKET: MIDDLE EAST & AFRICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 MIDDLE EAST & AFRICA REFRACTIVE SURGERY DEVICES MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 MIDDLE EAST & AFRICA REFRACTIVE SURGERY DEVICES MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 MIDDLE EAST & AFRICA REFRACTIVE SURGERY DEVICES MARKET: DBMR MARKET POSITION GRID
FIGURE 8 MIDDLE EAST & AFRICA REFRACTIVE SURGERY DEVICES MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 9 MIDDLE EAST & AFRICA REFRACTIVE SURGERY DEVICES MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 MIDDLE EAST & AFRICA REFRACTIVE SURGERY DEVICES MARKET: SEGMENTATION
FIGURE 11 INCREASING TECHNOLOGICAL ADVANCEMENTS IN THE REFRACTIVE SURGERY DEVICES ARE EXPECTED TO DRIVE THE MIDDLE EAST & AFRICA REFRACTIVE SURGERY DEVICES MARKET IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 12 PRODUCT TYPE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST & AFRICA REFRACTIVE SURGERY DEVICES MARKET IN 2022 & 2029
FIGURE 13 NORTH AMERICA IS EXPECTED TO DOMINATE THE MIDDLE EAST & AFRICA REFRACTIVE SURGERY DEVICES MARKET, AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 14 DRIVERS, RESTRAINT, OPPORTUNITIES, CHALLENGES FOR MIDDLE EAST & AFRICA REFRACTIVE SURGERY DEVICES MARKET
FIGURE 15 MIDDLE EAST & AFRICA REFRACTIVE SURGERY DEVICES DISEASE MARKET: BY PRODUCT TYPE, 2021
FIGURE 16 MIDDLE EAST & AFRICA REFRACTIVE SURGERY DEVICES DISEASE MARKET: BY PRODUCT TYPE, 2020-2029 (USD MILLION)
FIGURE 17 MIDDLE EAST & AFRICA REFRACTIVE SURGERY DEVICES DISEASE MARKET: BY PRODUCT TYPE, CAGR (2022-2029)
FIGURE 18 MIDDLE EAST & AFRICA REFRACTIVE SURGERY DEVICES DISEASE MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 19 MIDDLE EAST & AFRICA REFRACTIVE SURGERY DEVICES DISEASE MARKET: BY SURGERY TYPE, 2021
FIGURE 20 MIDDLE EAST & AFRICA REFRACTIVE SURGERY DEVICES DISEASE MARKET: BY SURGERY TYPE, 2020-2029 (USD MILLION)
FIGURE 21 MIDDLE EAST & AFRICA REFRACTIVE SURGERY DEVICES DISEASE MARKET: BY SURGERY TYPE, CAGR (2022-2029)
FIGURE 22 MIDDLE EAST & AFRICA REFRACTIVE SURGERY DEVICES DISEASE MARKET: BY SURGERY TYPE, LIFELINE CURVE
FIGURE 23 MIDDLE EAST & AFRICA REFRACTIVE SURGERY DEVICES DISEASE MARKET: BY APPLICATION, 2021
FIGURE 24 MIDDLE EAST & AFRICA REFRACTIVE SURGERY DEVICES DISEASE MARKET: BY APPLICATION, 2020-2029 (USD MILLION)
FIGURE 25 MIDDLE EAST & AFRICA REFRACTIVE SURGERY DEVICES DISEASE MARKET: BY APPLICATION, CAGR (2022-2029)
FIGURE 26 MIDDLE EAST & AFRICA REFRACTIVE SURGERY DEVICES DISEASE MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 27 MIDDLE EAST & AFRICA REFRACTIVE SURGERY DEVICES DISEASE MARKET: BY END USER, 2021
FIGURE 28 MIDDLE EAST & AFRICA REFRACTIVE SURGERY DEVICES DISEASE MARKET: BY END USER, 2020-2029 (USD MILLION)
FIGURE 29 MIDDLE EAST & AFRICA REFRACTIVE SURGERY DEVICES DISEASE MARKET: BY END USER, CAGR (2022-2029)
FIGURE 30 MIDDLE EAST & AFRICA REFRACTIVE SURGERY DEVICES DISEASE MARKET: BY END USER, LIFELINE CURVE
FIGURE 31 MIDDLE EAST & AFRICA REFRACTIVE SURGERY DEVICES DISEASE MARKET: BY DISTRIBUTION CHANNEL, 2021
FIGURE 32 MIDDLE EAST & AFRICA REFRACTIVE SURGERY DEVICES DISEASE MARKET: BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
FIGURE 33 MIDDLE EAST & AFRICA REFRACTIVE SURGERY DEVICES DISEASE MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029)
FIGURE 34 MIDDLE EAST & AFRICA REFRACTIVE SURGERY DEVICES DISEASE MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 35 MIDDLE EAST AND AFRICA REFRACTIVE SURGERY DEVICES MARKET: SNAPSHOT (2021)
FIGURE 36 MIDDLE EAST AND AFRICA REFRACTIVE SURGERY DEVICES MARKET: BY COUNTRY (2021)
FIGURE 37 MIDDLE EAST AND AFRICA REFRACTIVE SURGERY DEVICES MARKET: BY COUNTRY (2022 & 2029)
FIGURE 38 MIDDLE EAST AND AFRICA REFRACTIVE SURGERY DEVICES MARKET: BY COUNTRY (2021 & 2029)
FIGURE 39 MIDDLE EAST AND AFRICA REFRACTIVE SURGERY DEVICES MARKET: BY PRODUCT TYPE (2022-2029)
FIGURE 40 MIDDLE EAST & AFRICA REFRACTIVE SURGERY DEVICES MARKET: COMPANY SHARE 2021 (%)
研究方法
数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。该阶段包括通过各种来源和策略获取市场信息或相关数据。它包括提前检查和规划从过去获得的所有数据。它同样包括检查不同信息源中出现的信息不一致。使用市场统计和连贯模型分析和估计市场数据。此外,市场份额分析和关键趋势分析是市场报告中的主要成功因素。要了解更多信息,请请求分析师致电或下拉您的询问。
DBMR 研究团队使用的关键研究方法是数据三角测量,其中包括数据挖掘、数据变量对市场影响的分析和主要(行业专家)验证。数据模型包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、专利分析、定价分析、公司市场份额分析、测量标准、全球与区域和供应商份额分析。要了解有关研究方法的更多信息,请向我们的行业专家咨询。
可定制
Data Bridge Market Research 是高级形成性研究领域的领导者。我们为向现有和新客户提供符合其目标的数据和分析而感到自豪。报告可定制,包括目标品牌的价格趋势分析、了解其他国家的市场(索取国家列表)、临床试验结果数据、文献综述、翻新市场和产品基础分析。目标竞争对手的市场分析可以从基于技术的分析到市场组合策略进行分析。我们可以按照您所需的格式和数据样式添加您需要的任意数量的竞争对手数据。我们的分析师团队还可以为您提供原始 Excel 文件数据透视表(事实手册)中的数据,或者可以帮助您根据报告中的数据集创建演示文稿。

